Press "esc" to clear
Go to Advanced Search

Showing results

5160 of 3263

Article ID: 698053

Lowering Blood Pressure Reduces Risk of Mild Cognitive Impairment, Dementia

University of Alabama at Birmingham

Preliminary results of the SPRINT MIND trial found that lowering one’s systolic blood pressure to 120 mm Hg reduces the risk of mild cognitive impairment and dementia.

Released:
25-Jul-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698003

Newly Identified Target May Help with Drug Discovery for Chronic Inflammatory Diseases

University of California San Diego Health

In a study published online July 25 in the journal Nature, University of California San Diego School of Medicine researchers identified a signaling pathway that activates the NLRP3 inflammasome implicated in several severe chronic inflammatory disorders.

Released:
25-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697909

Thomas Jefferson University Announces the first Optimizer® Smart Device Implantation

Thomas Jefferson University

First Optimizer® Smart investigational device for heart disease implanted in the Philadelphia Area

Released:
25-Jul-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697859

Women and Older People Under-Represented in Drug Trials for Heart Disease

Universite de Montreal

In the U.S., it's estimated the number of people aged 65 and older will double over the next 30 years. With the first baby boomers now turning 73, the demand for cardiac care is expected to skyrocket, not just in the U.S. but elsewhere as well. Even though they have more cardiovascular problems, fewer women and people over 65 are recruited for randomized clinical trials than men and younger people. To find out, a team of researchers took a close look at the 25 most influential clinical trials for each year in the 20-year period from 1996 to 2015. They compared the age and sex of participants to data published in the U.S. National Health and Nutrition Examination Survey 2015-2016 on the prevalence of cardiovascular disease in America.

Released:
25-Jul-2018 6:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697775

An Enzyme’s Active Site Determines Its Reactivity

American Society for Biochemistry and Molecular Biology (ASBMB)

Phospholipases are enzymes that cleave the tail group off of phospholipids, which make up cell membranes. These tails, or free fatty acids, can go on to act as signaling molecules. Lysosomal phospholipase A2, or LPA2, is a phospholipase from the macrophages that protect the lung.

Released:
23-Jul-2018 1:45 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697783

Why Do Kidney Disease and Heart Failure Correlate?

American Society for Biochemistry and Molecular Biology (ASBMB)

People with chronic kidney disease are at unusually high risk of also developing cardiovascular disease; in fact, a patient with non-dialysis kidney disease is more likely to die of heart failure than to develop end-stage kidney failure. However traditional atherosclerosis risk factors contribute less strongly to cardiovascular disease in chronic kidney disease patients than in subjects with intact kidney function.

Released:
23-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
7-20-18Paige.jpg
  • Embargo expired:
    20-Jul-2018 5:00 AM EDT

Article ID: 697636

Drug Now in Clinical Trials for Parkinson’s Strengthens Heart Contractions in Animals

Johns Hopkins Medicine

A drug currently in clinical trials for treating symptoms of Parkinson’s disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers.

Released:
19-Jul-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697659

Diabetes during Pregnancy May Increase Baby’s Heart Disease Risk

American Physiological Society (APS)

Gestational diabetes may increase the risk of blood vessel dysfunction and heart disease in offspring by altering a smooth muscle protein responsible for blood vessel network formation. Understanding of the protein’s function in fetal cells may improve early detection of disease in children. The study is published ahead of print in the American Journal of Physiology—Cell Physiology.

Released:
19-Jul-2018 3:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
CrimpedandExpandedIMPEDE.jpg

Article ID: 697669

Memory Foam for Vascular Treatment Receives FDA Clearance

National Institute of Biomedical Imaging and Bioengineering

Shape Memory Medical recently announced FDA clearance for U.S. marketing of their IMPEDE Embolization Plug, a technology funded by NIBIB and created to block irregular blood vessels.

Released:
19-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    19-Jul-2018 5:00 AM EDT

Article ID: 697483

‘Good Cholesterol’ May Not Always be Good for Postmenopausal Women

Health Sciences at the University of Pittsburgh

Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol.’ The findings bring into question the current use of total HDL cholesterol to predict heart disease risk.

Released:
17-Jul-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

5160 of 3263





Chat now!